Showing 4301-4310 of 10505 results for "".
- TV Star, Mother of Four Larsa Pippen Shares Her UltraShape Storyhttps://practicaldermatology.com/news/ultrashape/2458944/UltraShape’s newest devotee, Larsa Pippen, Real Housewives of Miami Alumni, wife of six-time world champion NBA star Scottie Pippen, and fitness enthusiast, recently talked about her UltraShape experience, saying “UltraShape gives me more confidence. I eat well and exercise regularly,
- AbbVie Receives FDA Orphan Drug Designation for Humira for the Investigational Treatment of Moderate-to-Severe Hidradenitis Suppurativahttps://practicaldermatology.com/news/abbvie-receives-fda-orphan-drug-designation-for-humira-for-the-investigational-treatment-of-moderate-to-severe-hidradenitis-suppurativa/2458945/AbbVie announced that the FDA has granted Humira® (adalimumab) orphan drug designation for the investigational treatment of moderate-to-severe hidradenitis suppurativa (HS) (Hurley Stage II and Hurley Stage III disease), a painful, chronic inflammatory skin disease. AbbVie's su
- Viscot Medical Introduces Soffzone Neutral Zone Trayshttps://practicaldermatology.com/news/viscot-medical-introduces-soffzone-neutral-zone-trays/2458950/Intended to reduce the risk of sharps injuries, Viscot Medical’s Soffzone™ Neutral Zone trays were designed by a plastic surgeon for plastic surgeons. According to Viscot, the Soffzone™ Neutral Zone can be easily integrated into a sharps safety
- FDA Clears Syneron Candela's PicoWay Picosecond Laser for Treatment of Pigmented Lesionshttps://practicaldermatology.com/news/fda-clears-syneron-candelas-picoway-picosecond-laser-for-treatment-of-pigmented-lesions/2458961/The FDA cleared Syneron Medical Ltd.’s PicoWay® picosecond laser for the treatment of pigmented lesions. The PicoWay picosecond laser previously received FDA clearance for the removal of tattoos in November 2014 and was launched in the US late in the fourth quarter 2014. PicoWay
- Nestlé Skin Health Announces Leadership Teamhttps://practicaldermatology.com/news/nestl-skin-health-announces-leadership-team/2458993/Nestlé Skin Health announced organizational changes at top management level to support the company’s expanded market opportunity and ambition. “Our goal is to grow the number of people the company serves to over a billion within 10 years, by offering skin health solutions that
- Aclaris Therapeutics Announces Positive Results from Phase IIb Trial of A-101 for the Removal of Seborrheic Keratosishttps://practicaldermatology.com/news/aclaris-therapeutics-announces-positive-results-from-phase-iib-trial-of-a-101-for-the-removal-of-seborrheic-keratosis/2459016/Aclaris Therapeutics, Inc. announced positive results from a Phase IIb clinical trial of the Company’s lead drug, A-101. In the trial, A-101 demonstrated clinically and statistically significant improvements in clearing multiple seborrheic keratoses (SK). Though the lesions are benign, many
- FDA Approves Galderma's Soolantra to Treat Rosaceahttps://practicaldermatology.com/news/fda-approves-galdermas-soolantra-for-rosacea/2459038/The FDA approved Galderma’s Soolantra (ivermectin) Cream 1% for the once-daily topical treatment of inflammatory lesions, or bumps and pimples, of rosacea. R Recent studies have further solidified that generally harmless microscopic Demodex mites may also be a culprit. These mites are norma
- Sienna Labs Obtains Fifth Patent Relating to Use of Plasmonic Nanoparticles in Treatment of Sebaceous Glands and Hairhttps://practicaldermatology.com/news/sienna-labs-obtains-fifth-patent-relating-to-use-of-plasmonic-nanoparticles-in-treatment-of-sebaceous-glands-and-hair/2459048/Siienna Labs was issued US Patent No. 8,895,071 covering, among other aspects, methods of using the company's plasmonic nanoparticle platform for localizing thermal damage to sebaceous glands and hair, a key mechanism for their investigational acne treatment and hair removal indications.
- DermSpectra Releases Total Body Digital Skin Imaging Systemhttps://practicaldermatology.com/news/dermspectra-releases-its-total-body-digital-skin-imaging-system/2459052/DermSpectra realease its DermSpectra Total Body Digital Skin Imaging System, which enables physicians to monitor critical skin changes (skin cancers, eczema, lesions, psoriasis, and rashes) over time. The DermSpectra advanced medical technology allows physicians to digitally capture and compare s
- Syneron Candela Expands Capabilities of UltraShape Platform, Receives FDA Clearance for the New U-Sculpt Transducer and Enhanced Ultrasound Powerhttps://practicaldermatology.com/news/20141117-syneron_candela_expands_capabilities_of_ultrashape_platform_receives_fda_clearance_for_the_new_u-sculpt_transducer_and_enhanced_ultrasound_power/2459064/The FDA cleared Syneron Medical Ltd.'s U-Sculpt transducer for the UltraShape non-invasive fat destruction platform. The FDA also cleared the V3.1 platform for a 25 percent increase in Ultrasound power in the new U-sculpt transducer and the previously cleared larger VDF transducer. This 25 percen